Skip to main content
. 2023 May 29;14:1183525. doi: 10.3389/fendo.2023.1183525

Table 2.

Medications for participants with PWS, frequency (%).

Medication Total (n=30) Male (n=19) Female (n=11)
Antipsychotic 11 (37%) 8 (42%) 3 (27%)
SSRI 10 (33%) 6 (32%) 4 (36%)
Levothyroxine 7 (23%) 4 (21%) 3 (27%)
Testosterone 7 (23%) 7 (37%)
Growth Hormone 8 (22%) 6 (32%) 2 (18%)
Oestrogen 5 (17%) 5 (46%)
Metformin 5 (17%) 4 (21%) 1 (9%)
Gliclazide 4 (13%) 2 (11%) 2 (18%)
Progesterone 2 (7%) 2 (19%)